Free Newsletter
AZ to appeal$215M Alabama judgment
A jury hit AstraZeneca with $215 million in damages as paybacks for overcharging the state of Alabama for drugs for 15 years. And AstraZeneca is just the first of 70 drug makers to go to trial. In 2005, Attorney General Troy King sued scores of pharma companies over Medicaid prices, and has settled with only two--Dey and Takeda Pharmaceuticals--which agreed to pay $6.75 million.
AstraZeneca says it's appealing the decision posthaste. The court allowed evidence from earlier pricing settlements "in clear violation of the rules of evidence," the company says. Plus, AstraZeneca claims, trial lawyers and state officials prejudiced potential jurors by making "negative public comments" before jury selection.
- check out AstraZeneca's release
- read this report
- see the item at Pharmalot
Related Article:
Drug companies must pay for Medicare pricing scheme. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: